Marrone Bio Innovations Inc
NASDAQ:MBII
Income Statement
Earnings Waterfall
Marrone Bio Innovations Inc
Revenue
|
44.4m
USD
|
Cost of Revenue
|
-17.9m
USD
|
Gross Profit
|
26.5m
USD
|
Operating Expenses
|
-43.9m
USD
|
Operating Income
|
-17.4m
USD
|
Other Expenses
|
-3.5m
USD
|
Net Income
|
-20.9m
USD
|
Income Statement
Marrone Bio Innovations Inc
Jun-2012 | Sep-2012 | Dec-2012 | Mar-2013 | Jun-2013 | Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||||||||||||
Revenue |
6
N/A
|
5
-5%
|
7
+30%
|
7
+3%
|
8
+7%
|
9
+15%
|
8
-7%
|
9
+6%
|
10
+12%
|
10
+3%
|
9
-11%
|
8
-7%
|
9
+3%
|
9
+3%
|
10
+9%
|
10
+6%
|
12
+16%
|
13
+9%
|
14
+6%
|
16
+11%
|
17
+9%
|
18
+3%
|
18
+4%
|
18
+1%
|
18
-4%
|
19
+7%
|
21
+13%
|
26
+21%
|
27
+5%
|
28
+6%
|
29
+3%
|
30
+3%
|
35
+17%
|
37
+5%
|
38
+3%
|
40
+4%
|
40
+1%
|
41
+3%
|
44
+8%
|
44
+0%
|
|
Gross Profit | |||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
(7)
|
(7)
|
(8)
|
(9)
|
(11)
|
(9)
|
(10)
|
(10)
|
(9)
|
(9)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(11)
|
(10)
|
(10)
|
(10)
|
(11)
|
(12)
|
(13)
|
(13)
|
(13)
|
(14)
|
(15)
|
(16)
|
(16)
|
(15)
|
(16)
|
(16)
|
(17)
|
(18)
|
|
Gross Profit |
3
N/A
|
3
-12%
|
3
-3%
|
2
-13%
|
2
-15%
|
2
+6%
|
1
-46%
|
1
+11%
|
1
-3%
|
(0)
N/A
|
(0)
+14%
|
(1)
-283%
|
(1)
-5%
|
0
N/A
|
1
+139%
|
1
+62%
|
2
+176%
|
3
+41%
|
5
+31%
|
6
+33%
|
7
+10%
|
7
+9%
|
8
+7%
|
8
+3%
|
8
+3%
|
9
+11%
|
10
+15%
|
13
+28%
|
14
+8%
|
15
+7%
|
16
+5%
|
17
+4%
|
20
+21%
|
22
+7%
|
23
+5%
|
24
+6%
|
25
+2%
|
26
+4%
|
27
+6%
|
26
-3%
|
|
Operating Income | |||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(19)
|
(20)
|
(27)
|
(28)
|
(30)
|
(33)
|
(33)
|
(37)
|
(41)
|
(44)
|
(48)
|
(49)
|
(49)
|
(46)
|
(40)
|
(37)
|
(33)
|
(30)
|
(28)
|
(28)
|
(29)
|
(31)
|
(31)
|
(30)
|
(30)
|
(21)
|
(30)
|
(31)
|
(34)
|
(41)
|
(44)
|
(47)
|
(46)
|
(43)
|
(40)
|
(39)
|
(40)
|
(40)
|
(43)
|
(44)
|
|
Selling, General & Administrative |
(8)
|
(9)
|
(10)
|
(11)
|
(12)
|
(14)
|
(15)
|
(19)
|
(21)
|
(24)
|
(29)
|
(31)
|
(32)
|
(30)
|
(27)
|
(24)
|
(21)
|
(20)
|
(19)
|
(18)
|
(19)
|
(20)
|
(20)
|
(19)
|
(19)
|
(18)
|
(19)
|
(20)
|
(22)
|
(27)
|
(30)
|
(32)
|
(33)
|
(31)
|
(29)
|
(28)
|
(28)
|
(28)
|
(31)
|
(30)
|
|
Research & Development |
(10)
|
(11)
|
(13)
|
(13)
|
(15)
|
(16)
|
(18)
|
(19)
|
(19)
|
(20)
|
(19)
|
(18)
|
(17)
|
(16)
|
(14)
|
(12)
|
(11)
|
(11)
|
(10)
|
(10)
|
(10)
|
(11)
|
(11)
|
(11)
|
(11)
|
(10)
|
(11)
|
(11)
|
(12)
|
(13)
|
(14)
|
(14)
|
(13)
|
(12)
|
(11)
|
(11)
|
(11)
|
(11)
|
(12)
|
(13)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
|
Other Operating Expenses |
0
|
0
|
(4)
|
(4)
|
(4)
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(15)
N/A
|
(17)
-14%
|
(24)
-37%
|
(25)
-6%
|
(28)
-11%
|
(31)
-10%
|
(32)
-2%
|
(36)
-14%
|
(39)
-9%
|
(44)
-12%
|
(49)
-10%
|
(50)
-3%
|
(51)
-1%
|
(46)
+10%
|
(39)
+14%
|
(36)
+10%
|
(30)
+15%
|
(27)
+11%
|
(24)
+12%
|
(22)
+7%
|
(23)
-2%
|
(24)
-6%
|
(23)
+4%
|
(23)
+2%
|
(22)
+4%
|
(12)
+43%
|
(20)
-59%
|
(18)
+9%
|
(20)
-11%
|
(25)
-28%
|
(28)
-11%
|
(30)
-7%
|
(26)
+15%
|
(21)
+17%
|
(17)
+19%
|
(15)
+15%
|
(15)
-2%
|
(14)
+7%
|
(15)
-11%
|
(17)
-13%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(0)
|
(8)
|
(15)
|
(20)
|
(16)
|
(5)
|
1
|
6
|
0
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(5)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(8)
|
(13)
|
(11)
|
(10)
|
(8)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(2)
|
(1)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
7
|
0
|
5
|
(2)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
|
Total Other Income |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(6)
|
(8)
|
(9)
|
(9)
|
(3)
|
(2)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
Pre-Tax Income |
(15)
N/A
|
(26)
-66%
|
(39)
-51%
|
(46)
-18%
|
(44)
+4%
|
(36)
+18%
|
(31)
+14%
|
(31)
+2%
|
(39)
-28%
|
(47)
-21%
|
(52)
-9%
|
(53)
-3%
|
(54)
-1%
|
(49)
+9%
|
(44)
+11%
|
(41)
+6%
|
(37)
+10%
|
(34)
+7%
|
(31)
+9%
|
(29)
+5%
|
(30)
-2%
|
(31)
-4%
|
(31)
+1%
|
(29)
+8%
|
(26)
+9%
|
(22)
+16%
|
(23)
-3%
|
(21)
+6%
|
(23)
-9%
|
(35)
-51%
|
(37)
-6%
|
(40)
-8%
|
(36)
+10%
|
(26)
+28%
|
(20)
+22%
|
(16)
+19%
|
(17)
-1%
|
(16)
+7%
|
(17)
-7%
|
(21)
-27%
|
|
Net Income | |||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(15)
|
(26)
|
(39)
|
(46)
|
(44)
|
(36)
|
(31)
|
(31)
|
(39)
|
(47)
|
(52)
|
(53)
|
(54)
|
(49)
|
(44)
|
(41)
|
(37)
|
(34)
|
(31)
|
(29)
|
(30)
|
(31)
|
(31)
|
(29)
|
(26)
|
(22)
|
(23)
|
(21)
|
(23)
|
(35)
|
(37)
|
(40)
|
(36)
|
(26)
|
(20)
|
(16)
|
(17)
|
(15)
|
(17)
|
(21)
|
|
Net Income (Common) |
(15)
N/A
|
(26)
-66%
|
(39)
-51%
|
(46)
-18%
|
(44)
+4%
|
(36)
+18%
|
(31)
+14%
|
(31)
+2%
|
(39)
-28%
|
(47)
-21%
|
(52)
-9%
|
(53)
-3%
|
(54)
-1%
|
(49)
+9%
|
(44)
+11%
|
(41)
+6%
|
(37)
+10%
|
(34)
+7%
|
(31)
+9%
|
(29)
+5%
|
(30)
-2%
|
(31)
-4%
|
(31)
+1%
|
(29)
+8%
|
(26)
+9%
|
(22)
+16%
|
(23)
-3%
|
(21)
+6%
|
(23)
-9%
|
(35)
-51%
|
(37)
-6%
|
(40)
-8%
|
(36)
+10%
|
(26)
+28%
|
(20)
+23%
|
(16)
+19%
|
(17)
-1%
|
(15)
+7%
|
(17)
-7%
|
(21)
-26%
|
|
EPS (Diluted) |
-12.39
N/A
|
-20.36
-64%
|
-9.82
+52%
|
-35.98
-266%
|
-34.41
+4%
|
-2.82
+92%
|
-1.62
+43%
|
-1.57
+3%
|
-1.88
-20%
|
-1.94
-3%
|
-2.11
-9%
|
-2.18
-3%
|
-2.19
0%
|
-2
+9%
|
-1.79
+11%
|
-1.67
+7%
|
-1.5
+10%
|
-1.39
+7%
|
-1.26
+9%
|
-1.19
+6%
|
-1.02
+14%
|
-1
+2%
|
-0.98
+2%
|
-0.38
+61%
|
-0.24
+37%
|
-0.2
+17%
|
-0.2
N/A
|
-0.19
+5%
|
-0.21
-11%
|
-0.3
-43%
|
-0.28
+7%
|
-0.28
N/A
|
-0.25
+11%
|
-0.17
+32%
|
-0.13
+24%
|
-0.1
+23%
|
-0.09
+10%
|
-0.09
N/A
|
-0.09
N/A
|
-0.11
-22%
|